The Effects of PaCO2 Levels on Cerebral Metabolism and Perfusion During Induced Hypothermia.
NCT ID: NCT00766103
Last Updated: 2016-10-21
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
8 participants
INTERVENTIONAL
2006-12-31
2008-05-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Jugular Venous Oxygen Saturation During Therapeutic Hypothermia After Cardiac Arrest
NCT00870610
Comparing Therapeutic Hypothermia Using External and Internal Cooling for Post-Cardiac Arrest Patients
NCT00827957
Influence of Therapeutic Hypothermia on Resting Energy Expenditure
NCT00500825
Time-differentiated Therapeutic Hypothermia
NCT01689077
Mild Hypothermia in Acute Ischemic Stroke
NCT00987922
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
DIAGNOSTIC
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
crossover: hypo- and hypercarbia
mild hypo- and hyperventilation
induction of mild hypo- and hypercarbia
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
mild hypo- and hyperventilation
induction of mild hypo- and hypercarbia
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Tampere University Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Patrik Falkenbach
Md
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Critical Care Medicine Research Group/ department of intensive care
Tampere, Pirkanmaa, Finland
Countries
Review the countries where the study has at least one active or historical site.
Related Links
Access external resources that provide additional context or updates about the study.
Tampere University Hospital (Pirkanmaa hospital district) home page (in English)
Home page of the Science Center of Tampere University Hospital (in Finnish)
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
R06213
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.